A Message from the CEO of Bionews
Hi everyone,
I’m thrilled to share some exciting news! Bionews is evolving to better serve both patients and industry partners in the rare disease space. We've unveiled a fresh new look, reflecting our commitment to building a stronger ecosystem for everyone involved.???
What truly sets Bionews apart isn't the design (though we're quite proud of it!). It's our deep understanding of the rare disease landscape. More than half of our team members are part of these communities themselves. This firsthand experience shapes everything we do, from the content we create to the digital tools we develop.
This connection fuels a two-fold mission:
Think of Bionews as a bridge builder, connecting patients with the resources they need and industry partners with the engaged audience they seek. Together, we're creating a richer ecosystem of information, community and resources for the rare disease community.
Don't miss the latest insights from our "Living with Rare Disease" survey – it's packed with actionable patient perspectives.
With a familiar voice and a renewed focus, Bionews remains your strong supporter. Thank you for being a part of our journey.?
Warm regards,
CEO, Bionews
Driven by a passion to instill hope, I aim to empower the PH community and other rare disease communities to find their voice. Because united, we are stronger!
5 个月What an incredible sense of pride it is to have the opportunity to work with such a phenomenal team at Bionews! We continue to build on our relationships with partners while enriching the lives of our patient communities.
Strategic Drug Developer & Patient Advocate | Clinical Development | Rare Diseases | Actively Exploring New Opportunities
5 个月Chris - Like aged wine, Bionews only continues to get better. Honored to have worked with some of your talented staff in the past.
Brand and Marketing Manager at Bionews, Inc
5 个月It is a privilege to be a part of our ever-growing ecosystem at Bionews, and to strengthen connections by being a conduit for so many patients and partners.